0001562180-24-003373.txt : 20240409
0001562180-24-003373.hdr.sgml : 20240409
20240409193736
ACCESSION NUMBER: 0001562180-24-003373
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240405
FILED AS OF DATE: 20240409
DATE AS OF CHANGE: 20240409
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Linetsky David
CENTRAL INDEX KEY: 0001776729
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38977
FILM NUMBER: 24833932
MAIL ADDRESS:
STREET 1: C/O PHREESIA, INC.
STREET 2: 432 PARK AVENUE S., 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phreesia, Inc.
CENTRAL INDEX KEY: 0001412408
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
ORGANIZATION NAME: 07 Trade & Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0131
BUSINESS ADDRESS:
STREET 1: 1521 CONCORD PIKE
STREET 2: SUITE 301 PMB 221
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 888-654-7473
MAIL ADDRESS:
STREET 1: 1521 CONCORD PIKE
STREET 2: SUITE 301 PMB 221
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: Phreesia Inc
DATE OF NAME CHANGE: 20070914
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-04-05
false
0001412408
Phreesia, Inc.
PHR
0001776729
Linetsky David
C/O PHREESIA, INC.
1521 CONCORD PIKE, SUITE 301 PMB 221
WILMINGTON
DE
19803
false
true
false
false
SVP, Life Sciences
false
Common Stock
2024-04-05
4
A
false
6105.00
A
210164.00
D
Common Stock
2024-04-05
4
A
false
508.00
A
7603.00
I
By Spouse
Represents Restricted Stock Units ("RSUs") that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's cash bonus earned for the fiscal year ended January 31, 2024 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert 50% of such cash bonus into RSUs representing 115% of the earned cash bonus amount. The number of RSUs granted are based on a per share value of $21.79, the closing price of the Issuer's common stock on April 5, 2024.
Represents RSUs that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's spouse's cash bonus earned for the fiscal year ended January 31, 2024 under the Issuer's Variable Compensation Plan. The Reporting Person's spouse elected to convert such portion of her earned cash bonus into RSUs representing 115% of such amount. The number of RSUs granted are based on a per share value of $21.79, the closing price of the Issuer's common stock on April 5, 2024.
Alexis Lyons, as Attorney-in-Fact for David Linetsky
2024-04-09